| Literature DB >> 23065016 |
Fatih Mehmet Türkcü1, Harun Yüksel, Alparslan Şahin, Mehmet Murat, Yaşar Bozkurt, Ihsan Çaça.
Abstract
Phosphodiesterase-5 (PDE5) inhibitors are commonly used in the treatment of erectile dysfunction. There are a small number of case reports that associate this agent with central serous chorioretinopathy (CSCR). Our report presents the treatment approach to a 42-year-old patient who described blurred vision and metamorphopsia and was diagnosed with CSCR following the use of tadalafil, a PDE5 inhibitor.Entities:
Mesh：
Substances：
Year: 2012 PMID： 23065016 DOI： 10.1007/s10792-012-9646-x
Source DB: PubMed Journal: Int Ophthalmol ISSN： 0165-5701 Impact factor: 2.031